Search Results for: Chemotherapy

May 15, 2022May 15, 2022

Wild-type IDH1 inhibition enhances chemotherapy response in melanoma

Melanoma News

Publication date: May 13, 2022 Malignant melanoma is one of the most common types of cancer in the United States. Despite recent and well-described progress in melanoma treatment, advanced disease ... Read more

May 2, 2022May 2, 2022

Preclinical Evaluation of LVR01 Attenuated Salmonella as Neoadjuvant Intralesional Therapy in Combination with Chemotherapy for Melanoma Treatment.

Melanoma Literature

Publication date: May 01, 2022 Treatment of malignant melanoma has improved in the last few years owing to early detection and new therapeutic options. Still, management of advanced disease remains ... Read more

April 30, 2022April 30, 2022

Electrochemotherapy for metastatic cutaneous melanoma.

Melanoma Literature

Publication date: Apr 29, 2022 Concepts Keywords Clinical Antineoplastic drugs Cutaneous Melanoma Electrochemotherapy Chemotherapy Melanoma Medicine Oncol Cancer Clinical medicine Semantics Type Source Name pathway KEGG Melanoma disease MESH melanoma ... Read more

April 20, 2022April 20, 2022

Radiation Dose Aspects of Hepatic Artery Infusion Chemotherapy in Uveal Melanoma Patients with Liver Metastases.

Melanoma Literature

Publication date: Apr 18, 2022 In uveal melanoma patients, liver metastases can be treated by hepatic artery infusion chemotherapy (HAIC). During this procedure, melphalan or, less frequently, fotemustine is infused ... Read more

April 15, 2022April 15, 2022

In situ injectable hydrogel-loaded drugs induce anti-tumor immune responses in melanoma immunochemotherapy.

Melanoma Literature

Publication date: Mar 01, 2022 Melanoma is a highly aggressive tumor located in the skin, with limited traditional therapies. In order to reduce the side effects caused by traditional administration ... Read more

March 25, 2022March 25, 2022

Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PD-L1 Antibody Backpacks.

Melanoma Literature

Publication date: Mar 23, 2022 The pivotal factors affecting the survival rate of patients include metastasis and tumor recurrence after the resection of the primary tumor. Anti-PD-L1 antibody (aPD-L1) has ... Read more

February 25, 2022February 25, 2022

Oleanolic acid-conjugated human serum albumin nanoparticles encapsulating doxorubicin as synergistic combination chemotherapy in oropharyngeal carcinoma and melanoma.

Melanoma Literature

Publication date: Feb 25, 2022 Combination chemotherapy produces a superior therapeutic response than monotherapy in cancer. Human serum albumin and a naturally occurring cancer prophylactic/anticancer triterpenoid, oleanolic acid, were conjugated ... Read more

February 24, 2022February 24, 2022

The Mechanisms of Immune-chemotherapy with Nanocomplex Codelivery of pTRP-2 and Adjuvant of Paclitaxel against Melanoma.

Melanoma Literature

Publication date: Feb 22, 2022 Melanoma accounts for the highest proportion of all skin cancer deaths. Immune-chemotherapy has transformed anti-melanoma therapy and is a preferred first-line combination strategy for melanoma. ... Read more

May 24, 2022May 24, 2022

A Decade of Transformation in Melanoma Treatments

Melanoma News

Publication date: May 24, 2022 The trials that led to the approval showed an overall response rate (ORR) of just 10. 9% in patients with previously treated advanced melanoma, but ... Read more

May 22, 2022May 22, 2022

Anaphylactic reaction to carboplatin diagnosed by skin testing-a reliable tool in platinum-based immediate-type hypersensitivity reactions.

Melanoma Literature

Publication date: May 20, 2022 Immediate-type hypersensitivity reactions (IHRs) to carboplatin (CA) are most commonly reported in ovarian cancer patients. A 54-year-old woman with stage IV melanoma suffering from metastasis ... Read more